ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...

Relmada Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for oncology ...

For generations, men have been taught that standing to pee is natural, efficient, and even a badge of masculinity. Bathrooms ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic regimens ...

UTIs and constipation are linked, but UTIs do not directly cause constipation. Shared anatomy and factors, like pelvic floor stress, can connect UTIs and constipation. OTC treatments, like fiber ...

Adenocarcinoma of the bladder is rare, originating from glandular cells, and can be primary or secondary, requiring accurate diagnosis for appropriate treatment. Diagnosis involves cystoscopy, biopsy, ...

Relmada Therapeutics is advancing NDV-01, a novel intravesical therapy for NMIBC, into phase 3 clinical trials, with Max Kates, M.D., joining their advisory board. NDV-01 combines gemcitabine and ...

Positive 9-month follow-up data for NDV-01 showed a 92% overall response rate at any time in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety Secured FDA alignment on key ...

Independent 2025 Review Examines How NewEra Protect Combines Kidney Support, Bladder Strength, and Pelvic Floor Recovery. Backed by Clinical-Grade Ingredients and a Verified 60-Day Refund Guarantee.

From the Uresta Starter Kit, a woman selects one of the bladder support device sizes to find her best fit for comfort and effectiveness. A femtech startup is bringing a non-surgical solution for women ...

The working-age population in the United States is not growing, at least not enough to measure. With President Trump’s immigration enforcement, we may even have more people leaving the country than ...

This subject, which has lately become a more frequent topic of discussion, was reviewed by a committee at the International Consultation on Incontinence-Research Society (ICI-RS), and a summary of ...